1Shibagaki Y,Fujita T.Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP):can we differentiate one from the other? Hypertens Res,2005,28(1):89-95.
3Hwang WK,Chai LY,Ng HJ,et al.Therapeutic plasmapheresis for the treatment of the thrombotic thrombocytopenic purpura-haemolytic uraemic syndromes.Singapore Med J,2004,45(5):219-223.
5Fontana S.Treatment of thrombotic thrombocytopenic purpura.Vox Sang,2006,90(4):245-254.
6Zimmerhackl LB,Besbas N.Epidemiology,clinical presentation,and pathophysiology of atypical and recurrent hemolytic uremic syndrome.Semin Thromb Hemost,2006,32(2):113-120.
7Gatti S,Arru M,Regaiani P,et al.Successful treatment of hemolytic uremic syndrome after liver-kidney transplantation.J Nephrol,2003,16(4):586-590.
8Benitez C,Andresen M.Indications,adverse effects and results of plasmapheresis in critical care patients.Rev Med Chil,2005,133(12):1441-1448.
9Norda R,Berseus O.Adverse events and problems in therapeutic hemapheresis.A report from the Swedish registry.Transfus Apheresis Sci,2001,25(1):33-41.
10Reutter JC,Sanders KF.Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura.J Clin Apheresis,2001,16(3):134-138.